info@seagull-health.com
SeagullHealth
语言:
search

How should I use Tibsovo(Ivosidenib)?

TIBSOVO is administered orally at 500 mg once daily, with adjustments for toxicity or drug interactions.

Dosage Regimen and Modifications

The standard dosage for TIBSOVO is 500 mg taken once daily, with or without food, but avoiding high-fat meals. Tablets should be swallowed whole, not split or crushed. For patients with AML or MDS, treatment continues until disease progression or unacceptable toxicity, with a minimum 6-month duration to assess response. 

Dose interruptions or reductions are required for QTc prolongation (>480 msec), differentiation syndrome, or Grade ≥3 adverse reactions. When co-administered with strong CYP3A4 inhibitors (e.g., itraconazole), the dose is reduced to 250 mg daily. If a dose is missed, it should be taken ≥12 hours before the next scheduled dose.

Ivosidenib(Tibsovo)
Ivosidenib(Tibsovo)
Adult patients with relapsed or refractory acute myeloid leukemia.
WeChat Scan
Free Inquiry
Related articles
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations, and its standardized administration is crucial for treatment efficacy.Dosage, Adminis...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
Dosage and Administration, Recommended Dose of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an innovative isocitrate dehydrogenase-1 (IDH1) inhibitor, which represents a breakthrough in the treatment of hematological malignancies and solid tumors.Dosage and Administra...
Ivosidenib Package Insert
Ivosidenib is a targeted therapeutic drug for relapsed or refractory acute myeloid leukemia (AML) in patients with isocitrate dehydrogenase 1 (IDH1) mutation. This article will provide a comprehensive...
How to Use Ivosidenib
Ivosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor, indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who harbor an IDH1 mutation.How to ...
Dosage of Ivosidenib(Tibsovo) for adult use
The recommended dose of Ivosidenib(Tibsovo) for adults is 500 mg once daily until disease progression or unacceptable toxicity. Patients should take it orally on an empty stomach or after a meal,...
共 7 条
  • 1
  • 2
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved